Vascular Biogenics Common Stock

Vascular Biogenics (VBLT) currently reports a common stock of $850K as of June 2024. That compares with $180K in the prior-year period — up 385.1% year over year. Use the charts on this page to explore Vascular Biogenics's common stock history and peer comparisons.

Vascular Biogenics's common stock increased from $180K to $850K — a 385.1% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vascular Biogenics reported $850K in common stock as of June 2024. That compares with $180K in the prior-year period — up 385.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $850K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vascular Biogenics, and consider following VBLT for alerts when major investors trade the stock.

Vascular Biogenics is classified in the Healthcare sector. On common stock, it currently shows $850K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VBLT with unrelated industries.